Two Sigma Advisers’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-34,500
Closed -$3.99M 2710
2023
Q3
$3.99M Sell
34,500
-291,600
-89% -$31.3M 0.01% 846
2023
Q2
$33.5M Buy
326,100
+46,300
+17% +$4.88M 0.09% 218
2023
Q1
$30.5M Buy
279,800
+121,500
+77% +$13.4M 0.08% 240
2022
Q4
$18M Sell
158,300
-218,600
-58% -$18.2M 0.05% 370
2022
Q3
$23.3M Buy
376,900
+364,400
+2,915% +$25.5M 0.07% 287
2022
Q2
$997K Buy
+12,500
New +$1.18M ﹤0.01% 1595
2022
Q1
Sell
-11,100
Closed -$1.2M 3025
2021
Q4
$1.2M Buy
+11,100
New +$1.21M ﹤0.01% 1467
2021
Q2
Sell
-62,600
Closed -$5.76M 2831
2021
Q1
$5.76M Sell
62,600
-440,900
-88% -$37.2M 0.02% 797
2020
Q4
$36.8M Buy
503,500
+37,600
+8% +$2.79M 0.1% 218
2020
Q3
$36.2M Buy
465,900
+75,898
+19% +$5.22M 0.1% 194
2020
Q2
$21.7M Buy
390,002
+17,373
+5% +$743K 0.06% 305
2020
Q1
$11M Sell
372,629
-445,500
-54% -$15.1M 0.04% 452
2019
Q4
$29.6M Buy
818,129
+1,500
+0.2% +$46K 0.07% 302
2019
Q3
$22.2M Sell
816,629
-259,500
-24% -$6.71M 0.05% 343
2019
Q2
$25.9M Buy
1,076,129
+4,400
+0.4% +$112K 0.06% 337
2019
Q1
$28.3M Sell
1,071,729
-15,400
-1% -$365K 0.07% 324
2018
Q4
$21.2M Buy
1,087,129
+544,100
+100% +$10.7M 0.06% 362
2018
Q3
$10.6M Buy
543,029
+181,300
+50% +$3.45M 0.03% 563
2018
Q2
$5.99M Buy
361,729
+193,800
+115% +$2.96M 0.02% 779
2018
Q1
$2.38M Buy
167,929
+121,900
+265% +$1.8M 0.01% 1167
2017
Q4
$672K Buy
+46,029
New +$646K ﹤0.01% 1671
2017
Q2
Sell
-19,629
Closed -$290K 2475
2017
Q1
$290K Buy
+19,629
New +$318K ﹤0.01% 2099
2016
Q1
Sell
-16,429
Closed -$356K 2194
2015
Q4
$356K Buy
+16,429
New +$320K ﹤0.01% 1460
2015
Q2
Sell
-33,400
Closed -$867K 2154
2015
Q1
$867K Buy
+33,400
New +$612K 0.01% 1136
2014
Q3
Sell
-18,200
Closed -$288K 2878
2014
Q2
$288K Buy
+18,200
New +$260K ﹤0.01% 2035

Other funds holding HZNP